Tal Kan
About Tal Kan
Tal Kan is a researcher at Novocure with a background in cancer immunology and molecular biochemistry, holding a Ph.D. from Technion - Israel Institute of Technology.
Current Company
Tal Kan is currently working as a Researcher at Novocure. Novocure specializes in the treatment of cancer through innovative medical technologies. Kan's role at Novocure involves conducting in-depth research with a focus on improving cancer treatment methodologies.
Previous Employment at Technion - Israel Institute of Technology
Tal Kan held multiple roles at Technion - Israel Institute of Technology. From 2020 to 2021, Kan was a Teaching Assistant in Haifa, Israel, and from 2018 to 2021, served as an Assistant to the Behavioral Sciences Research Ethics Committee. Additionally, Kan worked as a Teaching Assistant from 2017 to 2020 and as a Research Assistant twice— first from 2014 to 2015 and earlier from 2011 to 2014. These roles involved aiding academic research, supporting ethical research practices, and contributing to academic teaching.
Academic Project Lead at Shenkar
Between 2017 and 2019, Tal Kan worked as an Academic Project Lead at Shenkar - Engineering. Design. Art. Kan’s responsibilities included overseeing academic projects and applying research findings to practical applications within an interdisciplinary framework. This role was based in Haifa, Israel.
Educational Background
Tal Kan earned a Doctor of Philosophy (Ph.D.) in Medical Sciences, Cancer Immunology, and Immunotherapy from Technion - Israel Institute of Technology, a program completed between 2015 and 2021. Prior to that, Kan obtained a Bachelor of Science (B.Sc.) in Molecular Biochemistry from the same institution, studying from 2010 to 2014.
Published Research and Conferences
Tal Kan has published multiple research papers in peer-reviewed journals, focusing on cancer biology and immunology. Additionally, Kan has presented research findings at various international conferences, particularly on cancer immunotherapy. These contributions highlight a dedicated effort to advance the field of cancer treatment and immunology.